Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
about
Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapyDetection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencingDystrophin-deficient large animal models: translational research and exon skippingNovel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophyDetection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophyRecombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophyA computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophyQuantitative Magnetic Resonance Imaging of Skeletal Muscle Disease.Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies.Skeletal muscle-specific ablation of gamma(cyto)-actin does not exacerbate the mdx phenotype.Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115Evaluation of neural damage in Duchenne muscular dystrophy patients.The screening of Duchenne muscular dystrophy patients for submicroscopic deletions.Localisation of Xp21 meiotic exchange points in Duchenne muscular dystrophy familiesThe clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol.Localisation and characterisation of dystrophin in the central nervous system of controls and patients with Duchenne muscular dystrophy.Sporadic lower limb hypertrophy and exercise induced myalgia in a woman with dystrophin gene deletion.Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophyAminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx miceInsertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy.Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy.Identification of de novo mutations of Duchénnè/Becker muscular dystrophies in southern Spain.Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.Improved diagnosis of Duchenne/Becker muscular dystrophyPersonalized exon skipping strategies to address clustered non-deletion dystrophin mutations.Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications.Stromal cell-derived factors in Duchenne muscular dystrophyGerm-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutationDirect and indirect estimation of the sex ratio of mutation frequencies in hemophilia ACommon sequence motifs at the rearrangement sites of a constitutional X/autosome translocation and associated deletion.Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.Localization of DNA sequences in region Xp21 of the human X chromosome: search for molecular markers close to the Duchenne muscular dystrophy locus.Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutExon deletion pattern in duchene muscular dystrophy in north west of iran.In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophyEarly diagnosis and secondary prevention of Duchenne muscular dystrophySequence analysis of the breakpoint regions of an X;5 translocation in a female with Duchenne muscular dystrophy.Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophyDystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice.Experience and strategy for the molecular testing of Duchenne muscular dystrophy.
P2860
Q24631244-9A318F0C-ABA1-4D14-9F54-DF4149843CA1Q24794339-10B610C7-7B88-4ED2-BAB9-1163E1CA4A45Q26781901-871C8277-477F-4A7B-A41F-97E0A8AF0569Q28480452-CA64A79E-2188-47DF-AA0E-E513FC3A2B9CQ30273955-B765BC75-7F7B-47C2-BF78-BD938B09678AQ30545559-381321AC-C527-4A28-8DF3-B2AC772DAF53Q30585089-37169C15-8387-4D11-9CE5-DF325C2EBE25Q31153274-579B313F-4B89-48C3-9186-46BC994F01FFQ33265240-D96FDFCD-B177-4238-B728-351E0A05F971Q33342786-B70D2CF2-F6F5-4B39-873E-18136719E96DQ33597405-51E06738-DA9F-4D44-8AC8-E64FEAF41891Q33614107-076C4485-3A12-4B01-86D5-75B89683BBE5Q33673987-D992AA09-957E-4CB3-A707-64394C6F616BQ33674003-6DD84864-903B-4276-BF92-7216D3843A28Q33679539-C82503D5-B904-4FE6-9347-7B953E06EDEFQ33732332-87B52548-5473-45B5-AB9E-EE1C6BF5EA7DQ33734762-944F4841-6F31-463E-B22A-68D29777B08CQ33867329-798757D8-254E-4BD4-9978-04DBF34AD11BQ33871190-2F3FFF3B-6136-4DF5-9548-46A0A5337D25Q33897836-1AD61D5A-5183-4CA3-9359-C7B56D131266Q33917072-095DA600-C8A7-452D-B74B-6CD7AF44C89CQ33970356-539101CA-8982-4A5B-8A9F-7CCAE280728AQ34041966-37CBDD67-3840-428D-81B5-36FC7B11EC4DQ34244158-D7352460-8E05-4D08-937C-5939A8B650F8Q34349200-501AACDB-EFC4-413D-B6AE-E4A63F5446AAQ34497055-B26727C4-58F3-4DDE-B6FA-7DE3C030CE62Q35135968-AFBFBA6E-5E72-48DA-9CC5-661E588D3282Q35194296-8CA539F5-D8C4-4150-A9D3-CF20550F8458Q35195163-0B9A3076-8F82-41D8-96DE-A83029C0D11BQ35195591-CDE91280-ACD1-442F-A404-8B39FD246B03Q35196969-B8BA7868-EB11-4233-918F-A129A60589D4Q35200204-C7E2CDCD-8682-4259-AB95-6BB1A6CBC0A5Q35247811-38914A36-41C7-4A68-AC71-9204B595932DQ35576460-DB13D610-2D36-4E6A-AC99-A866E22F603EQ35588627-13BC7EEE-6B4C-4B43-91A1-370A273E361FQ35625596-6AA91EBA-A28A-4FC1-AA00-2CDEE0EADEFBQ35644576-F706DF18-210D-4B0A-8163-7B7B266676A7Q35665202-F9AC8734-01D2-4BCD-98B0-40E7D1B71D39Q35779807-29F1427F-D196-4CCB-8F98-8D72BE7FB044Q35789975-8D1F6459-DC70-4AAF-89E5-C7F1C6C0EAB6
P2860
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
@en
type
label
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
@en
prefLabel
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
@en
P2860
P356
P1433
P1476
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
@en
P2093
P2860
P2888
P356
10.1007/BF00275183
P577
1984-01-01T00:00:00Z
P6179
1043879204